Autopsy report · NCT02990273
The Utility of Thromboelastography in Cirrhotic Patients Undergoing Endoscopic Procedures
Cause of deathFunding or business, also regulatory or ethics
“No funding source available which was required for IRB approval”
Life of this trial
- Registered 3 months before it started.
- Ran for about 4 years before it stopped.
- 1 participant enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Johns Hopkins University
- Sponsor type
- University, hospital or other
- Conditions
- Cirrhosis, Coagulopathy
- Interventions
- Blood transfusion
- Participants
- 1
Trials that died the same way
- Effect of Vascular Endothelial Growth Factor Blockers on Aqueous Humor Dynamics
“Limited resources; IRB approval was not maintained” - The Effects of Sensory Training On Pain Modulation, Cognition and Time to Fatigue in Healthy Adults
“Study was not approved for the IRB; we then had no funds to reapply” - Comparative Effectiveness Trial in the Treatment of Pediatric Plaque Morphea
“Unable to obtain IRB approval at all sites” - Cerebrovascular Reactivity Assessed With fNIRS as a Biomarker of TCVI After Acute Traumatic Brain Injury in Military
“funding ran out after unanticipated length of time ( for IRB approval, CRADA, and start letter” - Safety of Topical Tranexamic Acid in Total Joint Arthroplasty in High Risk Patients
“Study did not receive IRB approval, so did not start”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.